交联β-环糊精-可溶性淀粉聚合物的微球吸附防晒剂行为

以对甲氧基肉桂酸异辛酯(OMC)和交联β-环糊精-可溶性淀粉聚合物微球为原料,以OMC包封率和载料质量分数为评价指标,通过单因素设计对制备交联β-环糊精-可溶性淀粉聚合物微球吸附OMC的工艺条件进行了优化.结果表明:OMC:交联β-环糊精-可溶性淀粉聚合物微球=1∶100(质量比),50％乙醇溶液为溶剂,25℃下反应60min,包封率为63.63％,载料质量分数6.59％;在0-24h内,OMC在β-环糊精-可溶性淀粉聚合物微球中的累积释料率符合零级释放规律.     

紫外分光光度法测定阿霉素聚乳酸微球的含量

采用复乳-溶剂挥发法制备阿霉素聚乳酸微球,通过扫描电镜观察微球的形态,采用紫外分光光度法测定徽球中阿霉素的含量.结果表明,所制备的阿霉素聚乳酸微球外形圆整,阿霉素溶液在1.70-34.1μg/mL浓度范围内线性良好,校准曲线回归方程为A=0.0422C+0.1845,相关系数r为0.9997,平均回收率为99.5%(R...     

Fe_3O_4@SiO_2@CdTe磁性荧光复合微球的制备与表征

采用水热合成法和Stber法制备了氨基功能化SiO2包覆的Fe3O4磁性纳米微球Fe3O4@SiO2-NH2,它与巯基乙酸修饰的CdTe量子点通过酰胺缩合反应,将量子点键合到磁性微球上,制备出单分散性的Fe3O4@SiO2@CdTe磁性荧光双功能微球.用透射电子显微镜、X-射线衍射仪、荧光分光光度计、振动样品磁强计表征了该纳米复合微球的结构和性能.结果表明:Fe3O4@SiO2@CdTe磁性荧光复合微球单分散性好,平均粒径为470nm,饱和磁化强度为37.9emu/g,具有良好的超顺磁性和较高的荧光发光效率.     

水飞蓟宾生物粘附微球的制备

建立了水飞蓟宾生物粘附微球的最佳处方。通过单因素考察海藻酸钠浓度、氯化钙浓度、注射器针头规格、干燥方法4个因素对微球性质的影响规律,及L9(34)正交试验确定最佳处方为海藻酸钠浓度1.5%,氯化钙浓度0.1%,针头规格7#,40℃干燥。并对最佳处方制备得到的3批微球进行了外观形态、体外释放度、载药量以及粘附力测定,均符合质量检测要求。该处方制备工艺良好。     

壳核型磁性纳米纤维素微球的超声制备及表征

以纳米级的Fe3 O4液体作为磁核 ,在非水体系的纤维素DMAc(N N二甲基乙酰胺 ) /LiCl溶液中 ,使用包埋法 ,在超声波的辅助下制备得到了纳米尺度的壳核型磁性纤维素微球 .利用FT IR、XRD及AFM/MFM (原子力显微镜 /磁场力显微镜 )对得到的磁性微球进行了表征 ,证实该微球由磁性的核与纤维素的壳组成 ,微球大小为 30～ 5 0nm ,且具有良好的分散性 .并研究了超声条件对磁性微球尺寸的影响 .     

超微镍粒子/聚苯胺纳米复合材料制备及其表征

反相微乳液法 (inversemicroemulsionsystems ,W /O型 )是制备纳米复合材料有效而简单的液相化学制备方法[1,2 ] .本工作首次采用两步连续反相微乳液法原位聚合制备超微镍粒子 (Ni) /聚苯胺 (PANI)纳米复合材料 .首先 ,利用无机化合物之间的氧化还原反应 ,将十二烷基苯磺酸钠 (DBS)和NiCl2 溶液按一定比例加入锥形瓶中 ,再加入异戊醇和正庚烷混合溶剂 ,常温下电磁力搅拌 ,体系变得半透明 (淡黄色 )形成微乳溶液 (W /O型 )称为 (A) ;然后再配制DBS和NaBH4 与异戊醇和正庚烷混合溶剂 ,形成微乳溶液 (W /O型 )称为 (B) ;两步连续反相…     

CoFe2O4/空心微球复合体的制备与吸波性能

采用化学共沉淀法,在空心微球上包覆一层CoFe2O4,得到一种低密度的空心磁性微球．磁测量结果表明,磁场下退火制备的CoFe2O4样品反位缺陷减少,从而导致饱和磁化强度随退火磁场的增强而增大．吸波性能测试结果表明,包覆结构的CoFe2O4/空心球样品是一种轻质的微波吸收材料.     

CoFe_2O_4/空心微球复合体的制备与吸波性能

采用化学共沉淀法,在空心微球上包覆一层CoFe2O4,得到一种低密度的空心磁性微球.磁测量结果表明,磁场下退火制备的CoFe2O4样品反位缺陷减少,从而导致饱和磁化强度随退火磁场的增强而增大.吸波性能测试结果表明,包覆结构的CoFe2O4/空心球样品是一种轻质的微波吸收材料.     

α-Fe2O3磁性微球的合成及磁性能

以氯化铁（FeCl3·6H2O）和氨水（NH3·H2O）为原料,以十六烷基三甲基溴化铵（CTAB）为表面活性剂,采用沉淀法制备了氧化铁磁性微球.所得样品用XRD、SEM及SQUID-VSM等手段进行了表征.结果表明,所得氧化铁磁性微球为斜方六面体结构,其粒径大小在0.5-1.5μm范围,其剩余磁感应强度为0.06emu/g,矫顽力为1700Oe,表现出一定的铁磁性.     

磁性聚苯胺纳米微球的合成与表征

报道了具有核壳结构的Fe3 O4 聚苯胺磁性纳米微球的合成方法和表征结果 .微球同时具有导电性和磁性能 .在优化的实验条件下 ,可得到饱和磁化强度Ms 为 5 5 .4emu/g ,矫顽力Hc 为 6 2Oe的磁性微球 .微球的导电性随着微球中Fe含量的增加而下降 .微球的磁性能则随着Fe含量的增加而增大 .Fe3 O4 磁流体的粒径和磁性聚苯胺微球的粒径均在纳米量级 .纳米Fe3 O4 粒子能够提高复合物的热性能 .实验表明 ,磁流体和聚苯胺之间可能存在着一定的相互作用 ,但这种相互作用较为复杂 ,难于研究 .     

In vitro studies of cutaneous retention of magnetic nanoemulsion loaded with zinc phthalocyanine for synergic use in skin cancer treatment

In this study was developed a new nano drug delivery system (NDDS) based on association of biodegradable surfactants with biocompatible magnetic fluid of maguemita citrate derivative. This formulation consists in a magnetic emulsion with nanostructured colloidal particles. Preliminary in vitro experiments showed that the formulation presents a great potential for synergic application in the topical release of photosensitizer drug (PS) and excellent target tissue properties in the photodynamic therapy (PDT) combined with hyperthermia (HPT) protocols. The physical chemistry characterization and in vitro assays were carried out by Zn(II) Phtalocyanine (ZnPc) photosensitizer incorporated into NDDS in the absence and the presence of magnetic fluid, showed good results and high biocompatibility. In vitro experiments were accomplished by tape-stripping protocols for quantification of drug association with different skin tissue layers. This technique is a classical method for analyses of drug release in stratum corneum and epidermis+dermis skin layers. The NDDS formulations were applied directly in pig skin (tissue model) fixed in the cell's Franz device with receptor medium container with a PBS/EtOH 20% solution (10 mM, pH 7.4) at 37 °C. After 12 h of topical administration stratum corneum was removed from fifty tapes and the ZnPc retained was evaluated by solvent extraction in dimetil-sulphoxide under ultrasonic bath. These results indicated that magnetic nanoemulsion (MNE) increase the drug release on the deeper skin layers when compared with classical formulation in the absence of magnetic particles. This could be related with the increase of biocompatibility of NDDS due to the great affinity for the polar extracelullar matrix in the skin and also for the increase in the drug partition inside of corneocites wall.     

Formulation development and evaluation of metronidazole magnetic nanosuspension as a magnetic-targeted and polymeric-controlled drug delivery system

A nanosuspension of magnetically tagged metronidazole was developed by the solvent displacement method coupled with ultrasonication and was evaluated for its physicochemical properties. The drug release from metronidazole magnetic nanosuspension at pH 1.2 and 7.0 shows maximum correlation coefficient for zero order and Higuchi model, respectively. The anthelmintic activity of the formulated metronidazole magnetic nanosuspension was evaluated on Indian earthworms (Pheretima poi). Metronidazole magnetic nanosuspension at a dose of 10 and 50 mg/ml shortened by 31% and 34%, respectively, the mean time to death of the earthworms when compared against a non-magnetic metronidazole suspension. Thus, the developed metronidazole magnetic nanosuspension showed potent, controlled and targeted drug action and might be a good therapeutic avenue in combating infectious GI disorders.     

Synthesis and characterization of polymeric nanospheres loaded with the anticancer drug paclitaxel and magnetic particles

We describe the preparation (by nanoprecipitation) and characterization of nanospheres (NPs) for magnetic drug targeting made of a magnetic fluid with poly(ethylene glycol), poly(d,l-lactic-co-glycolic acid) (PLGA), and the anticancer drug paclitaxel (Taxol^®). Infrared spectroscopy confirmed the incorporation of the drug in the PLGA NPs, which were also characterized in terms of morphology, size (typical diameter 200-250 nm) and colloidal stability in aqueous solutions of NaCl. Drug release and in vivo toxicity experiments of the prepared samples were performed. Their stability, magnetic properties (superparamagnetism), and lethal dose were found to be acceptable for the proposed application in cancer therapy.     

Drug Controlled Release and Biological Behavior of Poly(D,L-Lactide-Co-Glycolide) Microspheres

Poly(D,L-lactide-co-glycolide) (PLGA, 75/25) microspheres loaded with bovine serum albumin (BSA) were prepared using the W/O/W emulsification solvent evaporation technique. The cytotoxicity in vitro of PLGA microspheres was investigated and the BSA release from PLGA microspheres was also studied. Scanning electron micrographs showed that the PLGA microspheres were regular and the surface was smooth. BSA release typically began with an initial burst and then became steady. Analysis of the PLGA microspheres cytotoxicity showed that they had no cytotoxic effect and behaved very similar to the negative control of polystyrene. The hemolysis rate of the PLGA microspheres was 0.148%, suggesting it had no potential to induce hemolysis. The results show that PLGA microspheres may provide a useful controlled release protein drug system for used in pharmaceutics.     

Temperature and magnetic field responsive hyaluronic acid particles with tunable physical and chemical properties

We report the preparation and characterization of thiolated-temperature-responsive hyaluronic acid-cysteamine-N-isopropyl acrylamide (HA-CYs-NIPAm) particles and thiolated-magnetic-responsive hyaluronic acid (HA-Fe-CYs) particles. Linear hyaluronic acid (HA) crosslinked with divinyl sulfone as HA particles was prepared using a water-in-oil micro emulsion system which were then oxidized HA-O with NaIO₄ to develop aldehyde groups on the particle surface_. HA-O hydrogel particles were then reacted with cysteamine (CYs) which interacted with aldehydes on the HA surface to form HA particles with cysteamine (HA-CYs) functionality on the surface. HA-CYs particles were further exposed to radical polymerization with NIPAm to obtain temperature responsive HA-CYs-NIPAm hydrogel particles. To acquire magnetic field responsive HA composites, magnetic iron particles were included in HA to form HA-Fe during HA particle preparation. HA-Fe hydrogel particles were also chemically modified. The prepared HA-CYs-NIPAm demonstrated temperature dependent size variations and phase transition temperature. HA-CYs-NIPAm and HA-Fe-CYs particles can be used as drug delivery vehicles. Sulfamethoxazole (SMZ), an antibacterial drug, was used as a model drug for temperature-induced release studies from these particles.     

Preparation of magnetic polylactic acid microspheres and investigation of its releasing property for loading curcumin

In order to obtain a targeting drug carrier system, magnetic polylactic acid (PLA) microspheres loading curcumin were synthesized by the classical oil-in-water emulsion solvent-evaporation method. In the Fourier transform infrared spectra of microspheres, the present functional groups of PLA were all kept invariably. The morphology and size distribution of magnetic microspheres were observed with scanning electron microscopy and dynamic light scattering, respectively. The results showed that the microspheres were regularly spherical and the surface was smooth with a diameter of 0.55-0.75 μm. Magnetic Fe₃O₄ was loaded in PLA microspheres and the content of magnetic particles was 12 wt% through thermogravimetric analysis. The magnetic property of prepared microspheres was measured by vibrating sample magnetometer. The results showed that the magnetic microspheres exhibited typical superparamagnetic behavior and the saturated magnetization was 14.38 emu/g. Through analysis of differential scanning calorimetry, the curcumin was in an amorphous state in the magnetic microspheres. The drug loading, encapsulation efficiency and releasing properties of curcumin in vitro were also investigated by ultraviolet-visible spectrum analysis. The results showed that the drug loading and encapsulation efficiency were 8.0% and 24.2%, respectively. And curcumin was obviously slowly released because the cumulative release percentage of magnetic microspheres in the phosphate buffer (pH=7.4) solution was only 49.01% in 72 h, and the basic release of curcumin finished in 120 h.     

Magnetic lipid nanoparticles loading doxorubicin for intracellular delivery: Preparation and characteristics

Tumor intracellular delivery is an effective route for targeting chemotherapy to enhance the curative effect and minimize the side effect of a drug. In this study, the magnetic lipid nanoparticles with an uptake ability by tumor cells were prepared dispersing ferroso-ferric oxide nanoparticles in aqueous phase using oleic acid (OA) as a dispersant, and following the solvent dispersion of lipid organic solution. The obtained nanoparticles with 200 nm volume average diameter and −30 mV surface zeta potential could be completely removed by external magnetic field from aqueous solution. Using doxorubicin (DOX) as a model drug, the drug-loaded magnetic lipid nanoparticles were investigated in detail, such as the effects of OA, drug and lipid content on volume average diameter, zeta potential, drug encapsulation efficiency, drug loading, and in vitro drug release. The drug loading capacity and encapsulation efficiency were enhanced with increasing drug or lipid content, reduced with increasing OA content. The in vitro drug release could be controlled by changing drug or lipid content. Cellular uptake by MCF-7 cells experiment presented the excellent internalization ability of the prepared magnetic lipid nanoparticles. These results evidenced that the present magnetic lipid nanoparticles have potential for targeting therapy of antitumor drugs.     

Ferrofluids of magnetic multicore nanoparticles for biomedical applications

For a variety of magnetically based biomedical applications, it is advantageous to use sedimentation stable suspensions of relatively large (d>20 nm) magnetic core-shell nanoparticles. Water-based suspensions of multicore nanoparticles were prepared by coating of the particles (synthesized by means of a modified alkaline precipitation method) with a carboxymethyldextran shell. The resulting ferrofluids were structurally and magnetically characterized. It was found that these fluids show a specific heating power of about 60 W/g (f=400 kHz, H=10 kA/m). This value was increased up to 330 W/g by a simple fractionation method based on centrifugation. Finally, the cellular uptake of the multicore nanoparticles was demonstrated.     

La0.3Ca0.7Mn1-xWxO3体系电荷有序的建立与融化

用标准的固相反应法制备了La0.3Ca0.7Mn1-xWxO3(0.00≤X≤0.15)多晶样品.通过对样品磁化强度-温度(M-T)曲线、磁化强度-磁场强度(MH)曲线及ESR谱的测量,研究了Mn位W掺杂对La0.3Ca0.7Mn1-xWxO3体系的磁相变的影响.结果表明,随着W掺杂量的增加,体系磁相变发生了复杂的变化过程.当掺杂量为0.00≤X≤0.08时,体系存在电荷有序(CO)相,反铁磁(AFM)/C0态共存于相变温度以下,电荷有序温度(Tco)随着W掺杂量的增加而增加.x≥0.12时,体系电荷有序态逐渐减弱并融化,在极低温度下存在顺磁-铁磁(PM-FM)相变.